<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://142-54-23-223.fusionmedialtd.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 26 Jun 2026 16:05:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://142-54-23-223.fusionmedialtd.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  8-K        EDAP TMS SA               For: Jun 26</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EDAP+TMS+SA+++++++++++++++For%3A+Jun+26/26698679.html</link>
   <description>si-local-file:///var/storage/secattach/20260626/26698679.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EDAP+TMS+SA+++++++++++++++For%3A+Jun+26/26698679.html</guid>
   <pubDate>Fri, 26 Jun 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	  </item>
  <item>
   <title>Form  8-K        EDAP TMS SA               For: Jun 26</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EDAP+TMS+SA+++++++++++++++For%3A+Jun+26/26698679.html</link>
   <description>si-local-file:///var/storage/secattach/20260626/26698679.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EDAP+TMS+SA+++++++++++++++For%3A+Jun+26/26698679.html</guid>
   <pubDate>Fri, 26 Jun 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	  </item>
  <item>
   <title>Form  8-K        EDAP TMS SA               For: Jun 26</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EDAP+TMS+SA+++++++++++++++For%3A+Jun+26/26698679.html</link>
   <description>si-local-file:///var/storage/secattach/20260626/26698679.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EDAP+TMS+SA+++++++++++++++For%3A+Jun+26/26698679.html</guid>
   <pubDate>Fri, 26 Jun 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	  </item>
  <item>
   <title>Lucid Capital Markets Starts EDAP TMS S.A. (EDAP) at Buy</title>
   <link>http://www.streetinsider.com/New+Coverage/Lucid+Capital+Markets+Starts+EDAP+TMS+S.A.+%28EDAP%29+at+Buy/26669462.html</link>
   <description>(Updated - June 22, 2026 6:22 AM EDT)

&lt;p&gt;Lucid Capital Markets initiates coverage on EDAP TMS S.A. (NASDAQ: EDAP) with a Buy rating and a price target of $10.00.&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;We initiate FOCL at BUY with a $10 price target. Here’s the setup: FOCL has a novel system, a high quality Level 1 comparative HIFU dataset, an established CPT 55880 reimbursement pathway, strong HIFU instrument/procedure growth, and a clean post-rebrand story, against a market that is still pricing the stock as the legacy EDAP.&quot;&lt;/p&gt;&lt;p&gt;For an analyst ratings summary and ratings history on EDAP TMS S.A. &lt;a href=&quot;http://www.streetinsider.com/rating_history.php?q=EDAP&quot;&gt;click here&lt;/a&gt;. For more</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/Lucid+Capital+Markets+Starts+EDAP+TMS+S.A.+%28EDAP%29+at+Buy/26669462.html</guid>
   <pubDate>Mon, 22 Jun 2026 06:22:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	  </item>
  <item>
   <title>Lucid Capital Markets Starts EDAP TMS S.A. (EDAP) at Buy</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Lucid+Capital+Markets+Starts+EDAP+TMS+S.A.+%28EDAP%29+at+Buy/26669462.html</link>
   <description>(Updated - June 22, 2026 6:22 AM EDT)

&lt;p&gt;Lucid Capital Markets initiates coverage on EDAP TMS S.A. (NASDAQ: EDAP) with a Buy rating and a price target of $10.00.&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;We initiate FOCL at BUY with a $10 price target. Here’s the setup: FOCL has a novel system, a high quality Level 1 comparative HIFU dataset, an established CPT 55880 reimbursement pathway, strong HIFU instrument/procedure growth, and a clean post-rebrand story, against a market that is still pricing the stock as the legacy EDAP.&quot;&lt;/p&gt;&lt;p&gt;For an analyst ratings summary and ratings history on EDAP TMS S.A. &lt;a href=&quot;http://www.streetinsider.com/rating_history.php?q=EDAP&quot;&gt;click here&lt;/a&gt;. For more</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Lucid+Capital+Markets+Starts+EDAP+TMS+S.A.+%28EDAP%29+at+Buy/26669462.html</guid>
   <pubDate>Mon, 22 Jun 2026 06:22:47 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>Form  8-K        EDAP TMS SA               For: Jun 01</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EDAP+TMS+SA+++++++++++++++For%3A+Jun+01/26583551.html</link>
   <description>si-local-file:///var/storage/secattach/20260601/26583551.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EDAP+TMS+SA+++++++++++++++For%3A+Jun+01/26583551.html</guid>
   <pubDate>Mon, 01 Jun 2026 16:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	  </item>
  <item>
   <title>Form  8-K        EDAP TMS SA               For: Jun 01</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EDAP+TMS+SA+++++++++++++++For%3A+Jun+01/26583551.html</link>
   <description>si-local-file:///var/storage/secattach/20260601/26583551.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EDAP+TMS+SA+++++++++++++++For%3A+Jun+01/26583551.html</guid>
   <pubDate>Mon, 01 Jun 2026 16:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	  </item>
  <item>
   <title>EDAP changes name to FocalTherics, shifts focus to robotic focal therapy</title>
   <link>http://www.streetinsider.com/Corporate+News/EDAP+changes+name+to+FocalTherics%2C+shifts+focus+to+robotic+focal+therapy/26570770.html</link>
   <description>

&lt;p&gt;EDAP TMS S.A. (NASDAQ: EDAP) announced it will operate under the new corporate name &quot;FocalTherics&quot; to reflect its focus on robotic focal therapy. The company will begin trading under the new ticker symbol &quot;FOCL&quot; at market open on June 1, 2026.&lt;/p&gt;

&lt;p&gt;The company plans to classify its Extracorporeal Shock Wave Lithotripsy (ESWL) and Distribution operating segments as discontinued operations beginning with second quarter 2026 financial results. CEO Ryan Rhodes said the new name derives from &quot;Focal Therapy&quot; and &quot;Therapeutics&quot; and aligns with the company's Focal One product brand.&lt;/p&gt;

&lt;p&gt;The ticker symbol change applies to the company's American Depositary Shares, with each representing</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/EDAP+changes+name+to+FocalTherics%2C+shifts+focus+to+robotic+focal+therapy/26570770.html</guid>
   <pubDate>Fri, 29 May 2026 07:30:18 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	  </item>
  <item>
   <title>EDAP changes name to FocalTherics, shifts focus to robotic focal therapy</title>
   <link>http://www.streetinsider.com/Corporate+News/EDAP+changes+name+to+FocalTherics%2C+shifts+focus+to+robotic+focal+therapy/26570770.html</link>
   <description>

&lt;p&gt;EDAP TMS S.A. (NASDAQ: EDAP) announced it will operate under the new corporate name &quot;FocalTherics&quot; to reflect its focus on robotic focal therapy. The company will begin trading under the new ticker symbol &quot;FOCL&quot; at market open on June 1, 2026.&lt;/p&gt;

&lt;p&gt;The company plans to classify its Extracorporeal Shock Wave Lithotripsy (ESWL) and Distribution operating segments as discontinued operations beginning with second quarter 2026 financial results. CEO Ryan Rhodes said the new name derives from &quot;Focal Therapy&quot; and &quot;Therapeutics&quot; and aligns with the company's Focal One product brand.&lt;/p&gt;

&lt;p&gt;The ticker symbol change applies to the company's American Depositary Shares, with each representing</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/EDAP+changes+name+to+FocalTherics%2C+shifts+focus+to+robotic+focal+therapy/26570770.html</guid>
   <pubDate>Fri, 29 May 2026 07:30:18 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	  </item>
  <item>
   <title>EDAP changes name to FocalTherics, shifts focus to robotic focal therapy</title>
   <link>http://www.streetinsider.com/Corporate+News/EDAP+changes+name+to+FocalTherics%2C+shifts+focus+to+robotic+focal+therapy/26570769.html</link>
   <description>

&lt;p&gt;EDAP TMS S.A. (NASDAQ: EDAP) announced it will operate under the new corporate name &quot;FocalTherics&quot; to reflect its focus on robotic focal therapy. The company will begin trading under the ticker symbol &quot;FOCL&quot; on June 1, 2026.&lt;/p&gt;

&lt;p&gt;The company plans to classify its Extracorporeal Shock Wave Lithotripsy and Distribution operating segments as discontinued operations beginning with second quarter 2026 financial results. The legal name will remain EDAP TMS S.A., with a formal name change requiring future shareholder approval.&lt;/p&gt;

&lt;p&gt;&quot;FocalTherics is derived from the words 'Focal Therapy' and 'Therapeutics,'&quot; said Ryan Rhodes, Chief Executive Officer. &quot;This new name and identity reflects and reinforces</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/EDAP+changes+name+to+FocalTherics%2C+shifts+focus+to+robotic+focal+therapy/26570769.html</guid>
   <pubDate>Fri, 29 May 2026 07:30:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	  </item>
  <item>
   <title>   EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy  </title>
   <link>http://www.streetinsider.com/Press+Releases/+++EDAP+Announces+Corporate+Name+Change+to+FocalTherics%E2%84%A2+to+Reflect+Exclusive+Focus+on+High-Growth+Robotic+Focal+Therapy++/26570756.html</link>
   <description>&lt;p&gt;, May  29, 2026  (GLOBE NEWSWIRE) -- &lt;b&gt;EDAP Announces Corporate Name Change to FocalTherics&lt;/b&gt;&lt;sup&gt;&lt;b&gt;™&lt;/b&gt;&lt;/sup&gt;&lt;b&gt; to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy &lt;/b&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;margin-bottom:6pt;&quot;&gt;&lt;i&gt;Company will Begin Trading Under New Ticker Symbol “FOCL” at Market Open on June 1, 2026&lt;/i&gt;&lt;/li&gt;&lt;li style=&quot;margin-bottom:6pt;&quot;&gt;&lt;i&gt;Company Intends to Report and Classify its Legacy Non-Core ESWL and Distribution Operating Segments &lt;/i&gt;as Discontinued Operations Beginning with Second Quarter 2026 Financial Results&lt;/li&gt;&lt;li style=&quot;margin-bottom:6pt;&quot;&gt;&lt;i&gt;Investor Day to be Held on June 1, 2026 to Highlight Company Vision and Long-Term Strategy under New FocalTherics Corporate Identity&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;AUSTIN, Texas, May 29, 2026 - EDAP</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/+++EDAP+Announces+Corporate+Name+Change+to+FocalTherics%E2%84%A2+to+Reflect+Exclusive+Focus+on+High-Growth+Robotic+Focal+Therapy++/26570756.html</guid>
   <pubDate>Fri, 29 May 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	  </item>
 </channel>
</rss>
